Option Bulls Pounce On Inovio Pharmaceuticals Inc (INO) Amid Vaccine News

Inovio Pharmaceuticals Inc (NASDAQ:INO) call options are hot thanks to promising data on the biotech's experimental chikungunya virus vaccine

Mar 22, 2016 at 11:41 AM
facebook X logo linkedin


While overall option volume remains light on an absolute basis, calls are nonetheless crossing at an accelerated clip today on biotech stock Inovio Pharmaceuticals Inc (NASDAQ:INO). Specifically, call volume is running at more than two times the intraday average, arriving in the 95th percentile of its annual range. The most popular option by far is the January 2017 12-strike call, though it's unclear how option traders are positioning themselves here. 

Call buying has historically been the go-to strategy in INO's options pits. For instance, over nine calls have been bought to open for every put during the past two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). However, some of this activity -- especially at out-of-the-money strikes -- may be due to short sellers buying insurance, since over one-fifth of INO's float is sold short, or 10.80 times its average daily trading volume. 

There's no question where analysts stand, though. All five that cover INO say it's a "strong buy," with the stock's average 12-month price target coming in at $19 -- more than twice the shares' current price, and in territory not charted since early 2005. 

This optimism is warranted by the fact that Inovio Pharmaceuticals Inc (NASDAQ:INO) has advanced 71% since its late-January two-year low of $4.50 -- boosted by some positive developments surrounding its Zika vaccine. Today, INO is up 6.2% at $7.70, after the company presented promising data on its experimental chikungunya virus vaccine

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI